FDA Investigator Anastasia G Lolas

Anastasia G Lolas has inspections in 6 countries as of 28 Mar 2023. Anastasia G Lolas has collaborated with a combinined 2441 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
10
Last Inspection Date:
28 Mar 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United Kingdom of Great Britain and Northern Ireland, Austria, Switzerland, United States of America, Lithuania, Belgium
Co-Investigator(s):
Alice S Tsao, Amy Devlin, PhD, Andrea Siegel, PhD, Anita Narula, PhD, Anita R Michael, Anjali Shukla, PhD, Ann Marie Montemurro, Ashutosh Rao, PhD, Bo Chi, PhD, Brandon C Heitmeier, Brenda W Uratani, PhD, Brooke K Higgins, Burnell M Henry, Carl A Anderson, Carolyn A Renshaw, Chaltu N Wakijra, Charles I Ann, Charles M Edwards, Christopher T Middendorf, Concepcion Cruz, Jr, Cynthia Jim, CSO, Dennis Cantellops Paite, Diane L Raccasi, Donald C Obenhuber, PhD, Dr. Barbara D Paul, PhD, Dr. Ralph M Bernstein, PhD, Erika V Butler, Frances Namuswe, PhD, Gerald B Seaborn, Jr, Gwyn G Dickinson, Helen B Ricalde, Herbert M Corbello, Ivis L Negrón, Ivis Lnegron Torres, Jacqueline Mdiaz Albertini, Jee Chung, PhD, Jennifer Swisher, PhD, John P Mistler, Jonathan W Chapman, Jorge L Guadalupe, Jose A Cruz, Jose Acruz Gonzalez, Jose M Cayuela, Juhong Liu, PhD, Julianne C Mccullough, Julie D Bringger, Kalavati Suvarna, PhD, Katherine E Jacobitz, Katherine Szestypalow, Kathy Lee, Kent C Faul, Kevin A Gonzalez, Kevin D Kallander, Kim Lthomas Cruse, Libia M Lugo, Linda N Thai, Linda Thai, LT Richard A Lyght, Madushini Dharmasena, PhD, Maria Cecilia Tami, PhD, Maria Gutierrez Lugo, PhD, Maria Joselopez Barragan, PhD, Marie F Morin, Marvin D Jones, Mary E Farbman, PhD, Mary E Storch, Matthew R Noonan, Maxwell Van Tassell, PhD, Meredith P Soehl, Investigator, Michael E Maselli, Michael Shanks, MS, Minh D Phan, Mra Davism, Mra Mcculloughj, Nadeem I Chaudhry, Nebil A Oumer, Nicholas A Violand, Omotunde O Osunsanmi, Patricia D Stahnke, Patricia Fhughes Troost, Peter R Lenahan, Philip F Istafanos, DMV, MS, Prabhu P Raju, Rachael O Oyewole, Rachel C Harrington, Ram Sihag, PhD, Ramesh Potla, PhD, Raquel Gonzalez, Raquel Gonzalez Rivera, Ravichandran Veerasamy, Rebecca Rodriguez, Reyes Candau Chacon, PhD, Richard Ledwidge (nmi), PhD, Robert C Coleman, Robert J Martin, Robert Rodriguez, Roger F Zabinski, Rose M Ashley, Russell J Glapion, Sang Bong Lee, Santos E Camara, Scott R Nichols, PhD, Seneca D Toms, Shadia Zaman, PhD, Sharon K Thoma, PharmD, Sidney B Priesmeyer, Stephen D Brown, Steven E Bowen, PhD, Steven Fong, MS, PhD, Susan P Bruederle, Tekalign Wondimu, Thomas E Friel, Thuy T Nguyen, LCDR, Thuy Y Nguyen, Tiara Nbrown Crosen, Tracy Denison, PhD, Vaishali J Patel, Vlada Matusovsky, William Hallett, PhD, Xiaokuang Lai, PhD, Xiaoshi Wang, Yanming An, PhD, Yasamin Ameri, Ying Xin Fan, PhD, Zhihao Qiu (Peter), PhD, Zhong Li, PhD

Anastasia G Lolas's Documents

Publish Date Document Type Title
January, 2009 FDA 483 FUJIFILM Diosynth Biotechnologies UK Ltd - Form 483, 2009-01-09

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more